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Worldwide congenital heart defects (CHD) are the leading cause of infant deaths owing to congenital anomalies.
Delay in diagnosing and operating in neonates with prostaglandin dependant CHD may lead to significant morbidity
and mortality.
Objectives: To assess the time interval needed for acceptance and transfer of patients with critical CHD to a ter-
tiary cardiac center and the impact on the patient’s survival.
Study design: Retrospective database reviews of all cases diagnosed to have prostaglandin dependant (PG) CHD
at Prince Sultan Cardiac Center-Qassim during a 43 months period (from May 2007 to December 2010).
Results: During the study period 104 patients were diagnosed to have PG dependant CHD. Patients with PG
dependant systemic circulation constitute 60% of patients. Patients with ventricular septal defect (VSD) associated
with coarctation of the aorta constituted 16% of patients. The mean waiting time for transfer to a tertiary cardiac cen-
ter was 10 ± 10 days. Twenty-two (21%) patients died while waiting for acceptance and transfer. Eleven patients were
diagnosed with hypoplastic left heart syndrome (HLHS). There was no significant difference in the waiting time for
those with or without HLHS, with a mean of 9 days for both. Six of our patients had infections with positive blood
cultures. The mean waiting period for those with proved infection was 25 days compared with 8 days for those with
no proved infection (p value < 0.005).
Conclusion: There are a significant number of patients with severe CHD who die while waiting for acceptance
and transfer to a tertiary cardiac center. The causes for delay could be the presence of infection, prematurity and low
birth weight. The limited numbers of tertiary cardiac centers in Saudi Arabia as well as cardiac ICU beds are among
the factors delaying the acceptance of patients requiring cardiac surgery.
 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
Keywords: Prostaglandin dependant congenital heart defects, Prince Sultan Cardiac Center-Qassim, Waiting timeCongenital heart disease (CHD) is ‘‘a grossstructural abnormality of the heart or intra-
thoracic great vessels that is actually or potentially
of functional significance’’ [1].
The incidence of severe CHD in the province of
Al-Qassim is 5.4 per 1000 live births [2]. Surgical1016–7315  2011 King Saud University.
Production and hosting by Elsevier B.V. All rights reserved.
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doi:10.1016/j.jsha.2011.10.004series document improving survival for many
heart defects in the last decades in developed
countries as well as in Saudi Arabia (SA) [3–6].
Neonates with prostaglandin (PG) dependant
CHD include a wide variety of lesions (PG
dependant systemic or pulmonary blood flow as
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arteries).
Patients diagnosed to have CHD in pediatric
hospitals need to be referred to a tertiary cardiac
center either for confirmation of the diagnosis
and/or for cardiac intervention (surgery or
catheterization).
Due to the limited number of tertiary cardiac
centers performing complex cardiac surgeries
and their centralization in two cities of SA, there
are patients who develop complications or even
die while waiting for transfer. In addition, there
are also a limited number of pediatric cardiac
intensive care beds. Delay of transfer and inter-
vention with such patients may lead to unavoid-
able complications or patient death.Table 1. Distribution of patients by main diagnosis arranged in
order of frequency.
Diagnosis Frequency Percent
VSD, CoA 17 16.3
HLHS 11 10.6
PS 11 10.6
TGA 11 10.6
CoA 10 9.6
DORV, CoA 5 4.8
AS 4 3.8
AVSD, CoA 4 3.8
AVSD, PA 4 3.8
PA/IVS 4 3.8
Shone complex 4 3.8
TGA, VSD 4 3.8
Tricuspid atresia 4 3.8
DILV, CoA 3 2.9
DORV, PA 2 1.9
AP window, CoA 1 1
DORV, IAA 1 1
DORV, PS 1 1
IAA 1 1
TGA, CoA 1 1
VSD, AS 1 1
Total 104 100
Abbreviations: AP window = aorto-pulmonary window, AS = aortic ste-
nosis, CoA = coarctation of the aorta, DILV = double inlet left ventricle,
DORV = double outlet right ventricle, IAA = interrupted aortic arch,
HLHS = hypoplastic left heart syndrome, PA/IVS = pulmonary atresia
with intact ventricular septum, PS = pulmonic stenosis, TGA = trans-
position of great arteries, VSD = ventricular septal defect.Materials and methods
Prince Sultan Cardiac Center-Qassim (PSCC-Q)
is the only center providing pediatric cardiac ser-
vices in the Al-Qassim province. All hospitals
and primary health centers in the province are
required by law to refer any child suspected to
have CHD, in any age group from neonate to
14 years of age, including those with innocent
murmurs, to PSCC-Q.
The pediatric cardiology team at PSCC-Q in-
cludes two consultants, registrars, echo techni-
cians and nurses. There is a 24 hour, 7 day/week
on-call team, who responds to any consultation
from anywhere in the region, with telephone and
fax facilities. There are also well equipped ambu-
lance facilities with portable ventilators.
For any patient with a suspected severe CHD at
any hospital in the governorate, patient will be
seen within few hours after consultation and pa-
tient stabilization. General pediatricians in the
province hospitals and primary health clinics
(PHCs) are advised to refer any neonates or in-
fants who are sick or present in shock for un-
known reasons for a pediatric cardiology
evaluation.
At the pediatric cardiology clinic in PSCC-Q we
usually see around 5000 cases per year. All babies
born at Al-Qassim province with a suspicion of
CHD will be referred within few hours to PSCC-
Q after stabilization and starting PG infusion if
indicated.
Patients will be evaluated. Routine history,
physical examination and ECG will be done for
every case. Echocardiography will be done for
every patient using Vivid 7 G.E. echo machine.
Complex cases will be discussed in the daily team
meeting.If the patient has PG dependant CHD he or she
will be admitted to our NICU at Maternity and
Children Hospital in Buraidah (MCH). This hospi-
tal is considered a referral center for pediatric pa-
tients in the region, with a six PICU beds, and a
well equipped NICU with a facility to ventilate
up to 20 neonates.
We retrospectively reviewed the database of the
pediatric cardiology department at PSCC-Q. Pa-
tients identified to have PG dependant lesions
were included. Lesions were coded using the cod-
ing scheme of the International Society of Cardiol-
ogy [6]. The waiting time for transfer was defined
as the time from faxing the report to the tertiary
center to the time of transferring the patient.
From the total waiting list we selected a group of
patients called the ‘‘ideal group’’ who are sup-
posed to be accepted immediately for cardiac
intervention. We define the ideal group as pa-
tients who have no contraindication for cardiac
intervention with an ideal body weight and gen-
eral condition. Ideally these patients should be ac-
cepted without delay. In other words, we excluded
patients with one or more of the following: hypo-
plastic left heart syndrome (HLHS), dysmorphic
or syndromic infants, patients proved to have
Figure 1. Distribution of cases by diagnostic group.
Figure 2. Percentage of expired cases waiting for transfer from the
total cases.
Table 2. Distribution of expired cases waiting for transfer by
diagnosis.
Diagnosis No. of expired
DILV, CoA 1
DORV, PA 1
DORV, PS 1
HLHS 1
IAA 1
PA/VSD 1
PA/IVS 2
PS 2
Tricuspid atresia 2
CoA 3
VSD, CoA 3
TGA 4
Total 22
Figure 3. Histogram of the waiting time for transfer to tertiary
cardiac centers.
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WAITING TIME FOR TRANSFERinfection, preterm infants, and patients with neu-
rologic insult.
Data were analyzed using SPSS 16 software. The
study was approved by the hospital research
committee.Results
From May 2007 until December 2010, 104 pa-
tients were identified to have PG dependant
CHD. These patients required referral to a tertiary
cardiac center. Patients with PG dependant sys-
temic circulation constituted 63%. Patients with
ventricular septal defect (VSD) associated with
coarctation of the aorta (CoA) constitute the larg-
est group of patients (16%) (Table 1, Fig. 1).
The mean waiting time for transfer to a tertiary
cardiac center was 10 days ± 10 days (Fig. 2).
Twenty-two (21%) patients died while waiting for
acceptance and transfer. Deceased patients were
from all diagnostic groups (Table 2) with no statis-
tically significant differences between the groups.
Table 3. Excluded non-ideal group of patients for transfer to
tertiary cardiac centers (total 25 cases) (those with HLHS,
dysmorphism, infection diaphragmatic hernia, single kidney
with renal impairment preterm or those with neurologic insult).
Some patients have more than one comorbid condition.
Diagnosis No. Comorbid conditions
HLHS 11 Single kidney, renal failure
AP
window,
CoA
1 Infection
AVSD, PA 1 Dysmorphic, Down syndrome
CoA 4 Dysmorphic, Down syndrome,
neurologic insult, preterm, infection
DORV,
CoA
1 Neurologic insult
DORV, IAA 1 Infection
TGA 1 Preterm
VSD, CoA 2 Diaphragmatic hernia, infection
Infection 6
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diaphragmatic hernia, and one had a single
kidney with renal impairment and were included
among the non-ideal group (Fig. 3).
Six of our patients had infections with positive
blood cultures which delayed their transfer to
the tertiary cardiac center. The mean waiting per-
iod for those with proved infection was 25 days
compared with 8 days for those with no proved
infection (p value < 0.005).
The non-ideal group of patients (total 25)
(Table 3), includes those with unfavorable
cardiac anatomy for repair as well as those with
co-morbid conditions like dysmorphism, infection
diaphragmatic hernia, single kidney with renal
impairment or neurologic insult (Table 4).
We compared the ideal and the non-ideal
groups. The mean waiting time was 8 days versus
16 days for the ideal and non-ideal groups, respec-
tively (p value = 0.004). While waiting for transfer 6Table 4. Mean waiting time for different diagnoses in
comparison with the total group.
Diagnosis No. (% from
total)
Waiting
time
p
value
Coarctation of the aorta 10 (9.6%) 10 0.940
Hypoplastic left heart
syndrome
11 (10.6%) 9 0.902
VSD, CoA 17 (16.3%) 10 0.793
Transposition of the
great arteries
16 (15.4%) 15 0.036
Proved to have infection 6 (5.8%) 25 0.000
Ideal patients for
transfer
82 (78.8%) 8 0.001
Waiting time for the non-ideal group was 18 days.
Waiting time for the rest of patients was 8–9 days.out of 25 patients died (24%) among the non-ideal
group, compared to 16 out of 82 patients (19%)
among the ideal group (p value = 0.192).Discussion
CHD has been defined as the presence of a
gross structural abnormality of the heart or intra-
thoracic great vessels that is actually or potentially
of functional significance [1,7].
These cardiovascular malformations include a
very wide range of abnormalities including: mild
deviations of no clinical consequence, deviations
that seriously interfere with the course of circula-
tion but may be surgically altered or repaired, or
deviations that may be incompatible with post-na-
tal life. Worldwide CHD is the leading cause of in-
fant deaths owing to congenital anomalies [8,9].
Surgical series document improving survival for
many heart defects in the last decades in devel-
oped countries as well as in SA [3–6,10].
The incidence of severe CHD in Al-Qassim
province is 5.4 per 1000 live births [2]. Patients
diagnosed in pediatric hospitals need to be re-
ferred to a tertiary cardiac center.
The stages of transfer of patients to tertiary car-
diac centers include:
(1) Diagnosing the patient at the primary hospital.
(2) Issuing a medical report, making sure that the patient is
not in sepsis.
(3) Faxing the medical report to the tertiary cardiac
center(s).
(4) Waiting for acceptance.
(5) After acceptance, transfer of the patient by ambulance or
Medevac Air Ambulance.
Due to the limited number of tertiary cardiac
centers performing complex pediatric cardiac sur-
geries and their centralization in two cities of SA,
as well as the limited number of ICU beds in the
present centers and the long waiting lists, there
are patients who develop complications or even
die while waiting for transfer to tertiary cardiac
centers.
Delay of transfer and intervention may lead to
unavoidable complications including but not lim-
ited to the development of infection, complica-
tions of prostaglandin infusion, complications of
artificial ventilation, development of pulmonary
hypertension, and even death.
In Al-Qassim province, due its position near
Riyadh, usually we do not need Medevac Air
Ambulance for transfer of patients, even those
who are ventilated.
In addition, we have an agreement with the
receiving center(s) that patients will be transferred
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the continuation of medical care.
In most of the cardiac centers there are limited
ICU beds and long waiting lists for cardiac surgery.
Infection was the most common cause of delay
of acceptance and transfer of patients to tertiary
cardiac centers with the aim of treating patients
with the proper antibiotics before transfer, so that
cardiac ICU beds will not be occupied with pa-
tients requiring medical management and will
be reserved for those going directly for cardiac
surgery. Six of our patients had infections with po-
sitive blood cultures which delayed their transfer
to the tertiary cardiac center. The mean waiting
period for those with proved infection was 25 days
compared with 8 days for those with no proved
infection (p value < 0.005).
Prematurity and low birth weight were also
among the reasons for delay in acceptance and
transfer of patients. This is because most centers
do not operate on those with a body weight less
than 2.5 kg, especially those requiring cardiopul-
monary bypass.
Among the ideal patients for cardiac surgery
with no co-morbid conditions the mean waiting
time was 8 days. Ideally this should not be ac-
cepted because such patients should undergo sur-
gery on an urgent basis. This delay could
contribute to the high mortality of 19% among
these patients. Death could be due to infection,
intractable heart failure, or multi-organ affection.
We have to stress that our data is the best sce-
nario because we do have a pediatric cardiology
service with good diagnostic abilities, as well as
geographic proximity to Riyadh. In some areas
the situation may be worse and there could be a
delay in the diagnosis, as well as a delay in trans-
fer leading to greater morbidity and mortality.
The possible solutions for these problems could
either be the opening of more centers or increas-
ing the bed capacity of the existing centers.Conclusion
There are a significant number of patients with
severe CHD who die while waiting for acceptanceand transfer to a tertiary cardiac center. The
causes for delay could be the presence of infec-
tion, prematurity and low birth weight. HLHS
could be a cause of rejection of patients for cardiac
surgery. The limited number of ICU beds in car-
diac centers as well as the number of cardiac cen-
ters in SA is a limiting factor delaying the
acceptance of patients requiring cardiac surgery.Conflict of interest
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